In one paragraphArticle in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
22 authors.
Dallas J SmithMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-5707-528X Philippe J DufresneLaboratoire de santé publique du Québec, Institut national de santé publique du Québec (INSPQ), Québec, Canada.
Warda MemonMicrobiology Laboratory, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Yalong LiDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Rodrigo Almeida-PaesLaboratório de Micologia, Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.ORCID 0000-0002-6639-6058 Gloria M GonzálezDepartamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
Huan MeiDepartment of Medical Mycology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
Ruoyu LiDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
Jasmijn JansenDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Yinggai SongDepartment of Dermatology and Venerology, Peking University First Hospital, Beijing, China.ORCID 0000-0002-1644-6942 Amir SeyedmousaviMicrobiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.ORCID 0000-0002-6194-7447 Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-4383-5994 Jochem B BuilDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0003-4031-0778 Andrew M BormanUK HAS National Mycology Reference Laboratory, Science Quarter, Southmead Hospital, Bristol, United Kingdom.ORCID 0000-0003-0585-5721 Funding
Molecular Epidemiology of Clinically Important Fungi and Pathobiology of Fungal InfectionsZIACL090088 · CLC · CLINICAL CENTER · PI SEYEDMOUSAVI, AMIR · 2022 to 2025
$0kFundação Carlos Chagas Filho de Apoio à Pesquisa do Estado do Rio de Janeiro (FAPERJ) E26/200.423/2026Intramural NIH HHS ZIA CL090088NIH HHS CL090088
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antifungal AgentsHyalohyphomycosisHypocrealesDrug Resistance, FungalHumansMicrobial Sensitivity TestsAntifungal Agentsantifungal resistanceepidemiological cutoff valueshyalohyphomycosisPurpureocillium lilacinum
Identifiers
PMID42626958
PMCPMC13556260
What OpenQuestion holds
Textmetadata
Read underepoch 390